Table of Contents

Global Antivirals Market Research Report 2019
1 Antivirals Market Overview
1.1 Product Overview and Scope of Antivirals
1.2 Antivirals Segment by Type (Product Category)
1.2.1 Global Antivirals Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Antivirals Production Market Share by Type (Product Category) in 2017
1.2.3 Generic
1.2.3 Branded
1.3 Global Antivirals Segment by Application
1.3.1 Antivirals Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Application 1
1.3.3 HIV
1.3.4 Hepatitis
1.3.5 HSV
1.3.6 Influenza
1.4 Global Antivirals Market by Region (2013-2025)
1.4.1 Global Antivirals Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Antivirals (2013-2025)
1.5.1 Global Antivirals Revenue Status and Outlook (2013-2025)
1.5.2 Global Antivirals Capacity, Production Status and Outlook (2013-2025)

2 Global Antivirals Market Competition by Manufacturers
2.1 Global Antivirals Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Antivirals Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Antivirals Production and Share by Manufacturers (2013-2018)
2.2 Global Antivirals Revenue and Share by Manufacturers (2013-2018)
2.3 Global Antivirals Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Antivirals Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antivirals Market Competitive Situation and Trends
2.5.1 Antivirals Market Concentration Rate
2.5.2 Antivirals Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Antivirals Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Antivirals Capacity and Market Share by Region (2013-2018)
3.2 Global Antivirals Production and Market Share by Region (2013-2018)
3.3 Global Antivirals Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Antivirals Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Antivirals Consumption by Region (2013-2018)
4.2 North America Antivirals Production, Consumption, Export, Import (2013-2018)
4.3 Europe Antivirals Production, Consumption, Export, Import (2013-2018)
4.4 China Antivirals Production, Consumption, Export, Import (2013-2018)
4.5 Japan Antivirals Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Antivirals Production, Consumption, Export, Import (2013-2018)
4.7 India Antivirals Production, Consumption, Export, Import (2013-2018)

5 Global Antivirals Production, Revenue (Value), Price Trend by Type
5.1 Global Antivirals Production and Market Share by Type (2013-2018)
5.2 Global Antivirals Revenue and Market Share by Type (2013-2018)
5.3 Global Antivirals Price by Type (2013-2018)
5.4 Global Antivirals Production Growth by Type (2013-2018)

6 Global Antivirals Market Analysis by Application
6.1 Global Antivirals Consumption and Market Share by Application (2013-2018)
6.2 Global Antivirals Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Antivirals Manufacturers Profiles/Analysis
7.1 Merck & Co
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Antivirals Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Merck & Co Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Antivirals Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Johnson & Johnson Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Teva Pharmaceutical Industries
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Antivirals Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Teva Pharmaceutical Industries Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 GSK
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Antivirals Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 GSK Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Mylan
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Antivirals Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Mylan Antivirals Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Gilead Sciences
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Antivirals Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Gilead Sciences Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 F. Hoffmann-La Roche AG
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Antivirals Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 F. Hoffmann-La Roche AG Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Bristol-Myers-Squibb
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Antivirals Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Bristol-Myers-Squibb Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 AbbVie
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Antivirals Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 AbbVie Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 Aurobindo Pharma
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Antivirals Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Aurobindo Pharma Antivirals Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Cipla
7.12 Dr Reddy’s

8 Antivirals Manufacturing Cost Analysis
8.1 Antivirals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antivirals

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Antivirals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antivirals Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Antivirals Market Forecast (2018-2025)
12.1 Global Antivirals Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Antivirals Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Antivirals Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Antivirals Price and Trend Forecast (2018-2025)
12.2 Global Antivirals Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Antivirals Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Antivirals Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Antivirals Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Antivirals Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Antivirals Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Antivirals Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Antivirals Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Antivirals Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer